QuantLogix Private Company Profile

← Back to list

Generate Biomedicines

Generative biology for novel protein therapeutics
Biotech 📍 Somerville, MA Founded 2018
Current Valuation
Private
PRIVATE
Generate Biomedicines, founded by Flagship Pioneering, uses generative AI to design entirely new protein therapeutics across modalities, advancing a pipeline of AI-generated drug candidates.

Company Profile

CEO
Mike Nally
Founded
2018
HQ
Somerville, MA
IPO Status
private

Fundraising Status

private

Products

  • Generative protein therapeutics platform

Competitors

Absci (ABSI) · Xaira Therapeutics · Isomorphic Labs
BiotechGenerative BiologyProteinsDrug Discovery
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of recent date. Refreshed quarterly.